Abstract
Background Significant left main coronary artery disease occurs in about 5–7% of patients undergoing coronary angiography. Coronary artery bypass graft (CABG) surgery was the standard acceptable way in treating these lesions. The introduction of drug eluting stents (DES) in mid 2003 has pushed the rate of clinical restenosis below 5% for most lesion types. This encourged the cardiologists to treat the LMCA with DES. Methods and results We implanted DES in 30 patients with denovo LMCA-Stenosis (middle age 69.9 ± 12.5 83% men). 25 patients (83%) had hypertension, 5 diabetes mellitus (17%), 22 hyperlipidemia (73.3%) and 16 were smokers (53.3%). We implanted Paclitaxel-Stents in 26 (87%) and 4 Sirolimus-Stents (13%). 11 patients (37%) with Stents Conclusion LMCA intervention is in the hands of experienced interventionalist technically possible and sure (without MACE), connected with an accepted rate of re-intervention.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call